Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Revenue ContractionContracting
Percentile Rank87
3Y CAGR-55.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-55.6%/yr
Annual compound
Percentile
P87
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$90000.00-
2024$0.00-100.0%
2023$81000.00-92.1%
2022$1.03M-10.0%
2021$1.14M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-